ASFV-G-ΔI177L Vaccine Safety in Adult Breeding Boars

Virginia Friedrichs published a study on April 29, 2026, investigating the safety of the ASFV-G-ΔI177L live attenuated vaccine in adult breeding boars. The dataset likely contains clinical, virological, and semen quality measurements from eight boars monitored over 28 days post-vaccination. Findings include clinical signs, viral detection in multiple samples, and reduced semen quality.

Use Cases

• Analyze vaccine-induced clinical manifestations based on fever, lethargy, and anorexia observations
• Assess viral shedding risk based on genome detection in blood, oral fluid, and semen
• Evaluate vaccine impact on reproductive health based on semen quality measurements
• Compare vaccine outcomes between recovered and succumbed animals based on viral load data

Strengths

• Data covers multiple sample types: blood, oral fluid, semen, and tissues
• Observation period spans 28 days post-vaccination
• Includes specific clinical endpoints: high fever, lethargy, anorexia

Limitations

• Row count is unknown, which may limit suitability assessment
• Column-level documentation is absent; field semantics must be inferred after download
• Dataset size is 340.5 KB, indicating a limited scope

Provenance

Source

Virginia Friedrichs via figshare

Collection Method

Experimental study monitoring eight intramuscularly vaccinated boars

Time Range

Observation period of 28 days post-vaccination

Freshness

Last updated 2026-04-29 05:57:56; freshness should be verified